FIBRINOGEN RECEPTOR ANTAGONISTIC AGENT
A fibrinogen receptor antagonist compound of the structure: A-B-C-Gly-Asp-D-E (I) wherein A, B, C, D and E are preferably defined as follows: A is L-asparagine, D-asparagine or acylated asparagine B is an L- or D-isomer of proline, thioproline, beta , beta -dimethylthioproline, or N-methylalanine; C...
Gespeichert in:
| Hauptverfasser: | , , |
|---|---|
| Format: | Patent |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | |
| container_volume | |
| creator | RASU EFU NATSUTO SUTEFUEN EFU BURADEI DANIERU EFU BUEEBAA |
| description | A fibrinogen receptor antagonist compound of the structure: A-B-C-Gly-Asp-D-E (I) wherein A, B, C, D and E are preferably defined as follows: A is L-asparagine, D-asparagine or acylated asparagine B is an L- or D-isomer of proline, thioproline, beta , beta -dimethylthioproline, or N-methylalanine; C is arginine; D is phenylalanine or tryptophan alpha -naphthylalanine, beta -napthlalanine,arginine or lysine; and E is OH. t |
| format | Patent |
| fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_JPH03118398A</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>JPH03118398A</sourcerecordid><originalsourceid>FETCH-epo_espacenet_JPH03118398A3</originalsourceid><addsrcrecordid>eNrjZFBz83QK8vTzd3f1UwhydXYNCPEPUnD0C3F09_fzDA7xdFZwBEqF8DCwpiXmFKfyQmluBkU31xBnD93Ugvz41OKCxOTUvNSSeK8ADwNjQ0MLY0sLR2Ni1AAA1qIj6w</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>FIBRINOGEN RECEPTOR ANTAGONISTIC AGENT</title><source>esp@cenet</source><creator>RASU EFU NATSUTO ; SUTEFUEN EFU BURADEI ; DANIERU EFU BUEEBAA</creator><creatorcontrib>RASU EFU NATSUTO ; SUTEFUEN EFU BURADEI ; DANIERU EFU BUEEBAA</creatorcontrib><description>A fibrinogen receptor antagonist compound of the structure: A-B-C-Gly-Asp-D-E (I) wherein A, B, C, D and E are preferably defined as follows: A is L-asparagine, D-asparagine or acylated asparagine B is an L- or D-isomer of proline, thioproline, beta , beta -dimethylthioproline, or N-methylalanine; C is arginine; D is phenylalanine or tryptophan alpha -naphthylalanine, beta -napthlalanine,arginine or lysine; and E is OH. t</description><language>eng</language><subject>CHEMISTRY ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PEPTIDES ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>1991</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=19910520&DB=EPODOC&CC=JP&NR=H03118398A$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25564,76547</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=19910520&DB=EPODOC&CC=JP&NR=H03118398A$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>RASU EFU NATSUTO</creatorcontrib><creatorcontrib>SUTEFUEN EFU BURADEI</creatorcontrib><creatorcontrib>DANIERU EFU BUEEBAA</creatorcontrib><title>FIBRINOGEN RECEPTOR ANTAGONISTIC AGENT</title><description>A fibrinogen receptor antagonist compound of the structure: A-B-C-Gly-Asp-D-E (I) wherein A, B, C, D and E are preferably defined as follows: A is L-asparagine, D-asparagine or acylated asparagine B is an L- or D-isomer of proline, thioproline, beta , beta -dimethylthioproline, or N-methylalanine; C is arginine; D is phenylalanine or tryptophan alpha -naphthylalanine, beta -napthlalanine,arginine or lysine; and E is OH. t</description><subject>CHEMISTRY</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PEPTIDES</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>1991</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZFBz83QK8vTzd3f1UwhydXYNCPEPUnD0C3F09_fzDA7xdFZwBEqF8DCwpiXmFKfyQmluBkU31xBnD93Ugvz41OKCxOTUvNSSeK8ADwNjQ0MLY0sLR2Ni1AAA1qIj6w</recordid><startdate>19910520</startdate><enddate>19910520</enddate><creator>RASU EFU NATSUTO</creator><creator>SUTEFUEN EFU BURADEI</creator><creator>DANIERU EFU BUEEBAA</creator><scope>EVB</scope></search><sort><creationdate>19910520</creationdate><title>FIBRINOGEN RECEPTOR ANTAGONISTIC AGENT</title><author>RASU EFU NATSUTO ; SUTEFUEN EFU BURADEI ; DANIERU EFU BUEEBAA</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_JPH03118398A3</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>1991</creationdate><topic>CHEMISTRY</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PEPTIDES</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>RASU EFU NATSUTO</creatorcontrib><creatorcontrib>SUTEFUEN EFU BURADEI</creatorcontrib><creatorcontrib>DANIERU EFU BUEEBAA</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>RASU EFU NATSUTO</au><au>SUTEFUEN EFU BURADEI</au><au>DANIERU EFU BUEEBAA</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>FIBRINOGEN RECEPTOR ANTAGONISTIC AGENT</title><date>1991-05-20</date><risdate>1991</risdate><abstract>A fibrinogen receptor antagonist compound of the structure: A-B-C-Gly-Asp-D-E (I) wherein A, B, C, D and E are preferably defined as follows: A is L-asparagine, D-asparagine or acylated asparagine B is an L- or D-isomer of proline, thioproline, beta , beta -dimethylthioproline, or N-methylalanine; C is arginine; D is phenylalanine or tryptophan alpha -naphthylalanine, beta -napthlalanine,arginine or lysine; and E is OH. t</abstract><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | |
| ispartof | |
| issn | |
| language | eng |
| recordid | cdi_epo_espacenet_JPH03118398A |
| source | esp@cenet |
| subjects | CHEMISTRY HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PEPTIDES PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS |
| title | FIBRINOGEN RECEPTOR ANTAGONISTIC AGENT |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-02T08%3A52%3A39IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=RASU%20EFU%20NATSUTO&rft.date=1991-05-20&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EJPH03118398A%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |